NCT00377377View on ClinicalTrials.gov

Oral Ghrelin Agonist in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

July 31, 2006

Conditions

Healthy Subjects

Interventions

DRUG

EP1572 (ghrelin agonist) oral and duodenal application

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER

NCT00377377 - Oral Ghrelin Agonist in Healthy Subjects | Biotech Hunter | Biotech Hunter